Related Stories
U.S. officials worry paralyzing illness may grow more common
How ‘completely avoidable’ measles cases continue to climb
Trial therapy for Ebola shows promise in NIH trial
Scientists: Progress made, but gaps still exist for Ebola antidote
Flu season becomes worst since records first kept
Flu kills 30 children in U.S.; rapidly rising rate worries health professionals, closes schools
Scientists seek super-shot for flu 100 years after pandemic
Gov’t scientists scramble to save research ahead of shutdown
Scientists seek super-shot for flu 100 years after pandemic
‘Severe’ flu season widespread across country with at least 2,500 dead
US enrolls volunteers in large test of possible Zika vaccine
Ebola vaccine fast-tracked after proven 100 percent effective in trials
NIH official: Don’t expect ‘broad’ Zika outbreak despite Florida cases; disease could hang around
Ebola funds run too dry to fight Zika, Obama’s health officials tell Congress
Photos
Quotations
Dr. Fauci said the NIH is aiming to test a vaccine that protects against a second group of flu viruses next year.
Novavax, a Maryland medical company, is developing better flu shot →
Dr. Fauci said the NIH doesn't have an efficacy goal in mind with this trial, but that he expects the vaccine to be between 55% and 60% effective.
